France · 
What does Seventure Partners invest in?
Seventure Partners invests most often at Venture and Series A (56% of the rounds on record), in sectors such as Digital Technologies, Life Sciences and Fintech.
Seventure Partners highlights
- 01
14 cheques in the last 12 months
- 02
Mostly Venture and Series A: 56% of its rounds
- 03
Sole investor in 37 rounds, median $2.8M
- 04
8 exits from the portfolio
What they do
- Type
- VC firm (from a list, unverified)
- Cheque size
- $1.0M – $10M as they say
- Stages
- SeedSeries ASeries BGrowth
- Sectors
- Digital TechnologiesLife SciencesFintech
- Based in
- Paris, France
- Cold pitches
- Not accepted
A website was listed for this organisation, but we could not confirm it belongs to the firm that wrote these cheques. Either the site never mentions them, or it turned out to be a different company sharing the name. We show neither it nor anything read from it. Tell us the right one.
The record
Every round we can evidence, newest first193 appearances
- 2026
12 rounds
- Sept
- Sept
- Sept
- Jul
- May
- May
- Apr
- Mar
- Feb
- Jan
- Jan
- Jan
- 2025
18 rounds
- DecBIOMx$3.0MWith 3 others
- Nov
- Oct
- Oct
- Oct
- Oct
- Sept
- Jul
- Jun
- May
- Apr
- Apr
- Mar
- Feb
- Feb
- Feb
- Jan
- Jan
- 2024
26 rounds
- Dec
- Dec
- Dec
- Dec
- Dec
- Nov
- Oct
- Oct
- Oct
- Oct
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration4 named
AAAlexandros AslanisChief Compliance OfficeriForm ADV
DMDavid ManjarresManaging PartneriForm ADV
IDIsabelle De CremouxChief Executive Officer, Managing DirectoriForm ADV
PAPierre AumeunierManaging Partner, Chief Financial OfficeriForm ADV
We also hold 28 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$115Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- Seventure Partners
- SEC number
- CRD 299870
Exits from the portfolio
Companies it backed that were later bought or listed8 in all
Santaris PharmaBought by Roche$450MAug 2014
Arkeia SoftwareBought by Western Digital TechnologiesUndisclosedJan 2013
FluxomeBought by EvolvaUndisclosedNov 2012
NetasqBought by Airbus GroupUndisclosedOct 2012
BoontyBought by NexwayUndisclosedDec 2008
An exit counts when it came after the firm's first round in the company. From historical deal records.